| Clinical data | |
|---|---|
| Trade names | Moderil, Cinnasil, Anaprel |
| Other names | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.042.232 |
| Chemical and physical data | |
| Formula | C35H42N2O9 |
| Molar mass | 634.726 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Rescinnamine, known by the brand namesModeril,Cinnasil, andAnaprel, is anangiotensin-converting enzyme inhibitor used as anantihypertensivedrug.
It is an indoloquinolizinealkaloid similar toreserpine, obtained fromRauvolfia serpentina[1] and otherspecies ofRauvolfia.[2]
Thisantihypertensive-related article is astub. You can help Wikipedia byadding missing information. |